CE-178253 benzenesulfonate salt, >=98% (HPLC)

CE-178253 benzenesulfonate salt, >=98% (HPLC)

Biochem/physiol Actions

CE-178253 is an extremely potent and selective CB1 antagonist with sub-nanomolar potency. In binding assays, CE-178253 has a 0.33 nM Ki for human CB1, vs. a Ki of > 10 mM for human CB2.

Features and Benefits

This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Legal Information

Pfizer is a registered trademark of Pfizer, Inc.

Sold for research purposes under agreement from Pfizer Inc.

Other Notes

This compound was developed by Pfizer for Neuroscience research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573605 CE-178253 benzenesulfonate salt, >=98% (HPLC) white to beige 100 PUVYOZFJBITEFT-UHFFFAOYSA-N 1S/C24H23Cl2N7O.C6H6O3S/c1-3-28-24(22(27)34)12-32(13-24)23-30-14(2)29-21-19(15-8-10-16(25)11-9-15)20(31-33(21)23)17-6-4-5-7-18(17)26;7-10(8,9)6-4-2-1-3-5-6/h4- SIGMA-ALDRICH powder ≥98% (HPLC)
£465.21 (exc VAT) per 25MG
-
+
3573606 CE-178253 benzenesulfonate salt, >=98% (HPLC) white to beige 100 PUVYOZFJBITEFT-UHFFFAOYSA-N 1S/C24H23Cl2N7O.C6H6O3S/c1-3-28-24(22(27)34)12-32(13-24)23-30-14(2)29-21-19(15-8-10-16(25)11-9-15)20(31-33(21)23)17-6-4-5-7-18(17)26;7-10(8,9)6-4-2-1-3-5-6/h4- SIGMA-ALDRICH powder ≥98% (HPLC)
£116.86 (exc VAT) per 5MG
-
+